Peptide Initiative

Peptides · Peptide comparison

Gonadorelin (GnRH) vs Triptorelin

The master hormone that controls your reproductive system and fertility

GnRH agonist that helps manage prostate cancer, endometriosis, and early puberty by controlling sex hormones

  • Hormone Support
  • Hormone Support

At a glance

Quick comparison

Dose rangeGonadorelin (GnRH)100–100 mcgTriptorelin11.25–11.25 mg
FrequencyGonadorelin (GnRH)Once dailyTriptorelinOnce daily
AdministrationGonadorelin (GnRH)Subcutaneous injectionTriptorelinIntramuscular injection
Cycle lengthGonadorelin (GnRH)Ongoing/indefiniteTriptorelinOngoing/indefinite
Onset speedGonadorelin (GnRH)Moderate (1-2 weeks)TriptorelinModerate (1-2 weeks)
Evidence levelGonadorelin (GnRH)Moderate human trials (Phase 1-2)TriptorelinStrong human trials (Phase 3 or FDA approved)

Efficacy

Benefit ratings

Reproductive Health

Gonadorelin (GnRH)95%
TriptorelinNo recorded rating

Hormone Balance

Gonadorelin (GnRH)90%
TriptorelinNo recorded rating

Ovulation Support

Gonadorelin (GnRH)88%
TriptorelinNo recorded rating

Hormone Regulation

Gonadorelin (GnRH)No recorded rating
Triptorelin94%

Cancer Management

Gonadorelin (GnRH)No recorded rating
Triptorelin90%

Endometriosis Relief

Gonadorelin (GnRH)No recorded rating
Triptorelin87%

Technical data

Compound specifications

Gonadorelin (GnRH)

Molecular formula
C55H75N17O13
Molecular weight
1182.3
Half-life
2-4 minutes
Bioavailability
Varies by route: ~5-20% (intranasal), 100% (IV/IM injections)
CAS number
34973-08-5

Triptorelin

Molecular formula
C64H82N18O13
Molecular weight
1311.4 g/mol
Half-life
2-3 hours (free peptide); 2-4 weeks (depot pamoate formulations)
Bioavailability
~100% (intramuscular/subcutaneous injection)
CAS number
57773-63-4

Protocols

Dosing compared

Gonadorelin (GnRH)

Subcutaneous

  • 100 mcgSingle dose · One-time diagnostic testFDA-labeled gonadotropin (LH/FSH) stimulation test for pituitary reserve; 100 mcg given once subcutaneously (or IV), with LH measured at 0, 15, 30, 45, 60 and 120 minutes (Factrel) [4].

Intravenous

  • 5 mcg per pulse (range 1-20 mcg)Every 90 minutes via pulsatile pump · One or more ovulatory cycles; reassessed at 21-day intervalsFDA-labeled pulsatile regimen for ovulation induction in hypothalamic amenorrhea (Lutrepulse); intravenous pulsatile delivery gave better results than subcutaneous [5]. The 2-4 minute half-life makes pulsatile delivery essential.

Triptorelin

Intramuscular injection

  • 3.75 mgOnce every 4 weeks · Ongoing while indicatedFDA-labeled 1-month depot (Trelstar) for advanced prostate cancer; single IM injection into either buttock [5].
  • 11.25 mgOnce every 12 weeks · Ongoing while indicatedFDA-labeled 3-month depot (Trelstar). Strengths are not additive; chosen by desired interval [5].
  • 22.5 mgOnce every 24 weeks · Ongoing while indicatedFDA-labeled 6-month depot (Trelstar for prostate cancer; Triptodur 22.5 mg for central precocious puberty, ages 2+) [5][6].

Applications

Best suited for

Gonadorelin (GnRH)

Improving fertility and conception chances
Gonadorelin (GnRH) is particularly well-suited for individuals focused on improving fertility and conception chances. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Regulating irregular menstrual cycles
Gonadorelin (GnRH) is particularly well-suited for individuals focused on regulating irregular menstrual cycles. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Enhancing reproductive hormone levels
Gonadorelin (GnRH) is particularly well-suited for individuals focused on enhancing reproductive hormone levels. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Supporting natural pregnancy attempts
Gonadorelin (GnRH) is particularly well-suited for individuals focused on supporting natural pregnancy attempts. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

Triptorelin

Managing advanced prostate cancer when combined with other treatments
Triptorelin is particularly well-suited for individuals focused on managing advanced prostate cancer when combined with other treatments. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Relieving severe endometriosis pain and symptoms
Triptorelin is particularly well-suited for individuals focused on relieving severe endometriosis pain and symptoms. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Delaying puberty development in children with early sexual maturation
Triptorelin is particularly well-suited for individuals focused on delaying puberty development in children with early sexual maturation. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

Safety profile

Side effects

Gonadorelin (GnRH)

Common

  • Mild headache
  • Local injection site reactions (redness, swelling)
  • Temporary hot flashes
  • Mood changes or emotional sensitivity
  • Nausea or mild stomach upset
  • Allergic skin reactions
  • Dizziness or lightheadedness
  • Temporary changes in vision
  • Joint or muscle aches
  • Insomnia or sleep disturbances
  • Severe allergic reactions (difficulty breathing, swelling)
  • Severe hormonal imbalance symptoms
  • Ovarian hyperstimulation syndrome (OHSS)
  • Signs of blood clots (chest pain, leg swelling)
  • Severe mood changes or depression

Serious

  • Severe allergic reaction

Triptorelin

No side effects recorded.

Research status

Safety & evidence

Gonadorelin (GnRH)

Evidence level
Moderate human trials (Phase 1-2)
FDA status
Previously FDA approved: FACTREL (1982) as a diagnostic test of pituitary gonadotropin reserve and LUTREPULSE (1989) for ovulation induction. Both human products are discontinued in the US.
Safety overview
Gonadorelin is native GnRH and carries the safety profile established over 40+ years of clinical use in reproductive endocrinology. As the body's natural hormone, it produces minimal local side effects when dosed appropriately. The critical safety concern with gonadorelin is the initial flare effect within 24-48 hours of first dose—temporary elevation in FSH and LH—which can paradoxically suppress sex hormones before the desired stimulation occurs. This flare makes gonadorelin unsuitable for some conditions and explains why synthetic analogs (agonists, antagonists) are preferred in many modern fertility protocols.

Contraindications

  • Pregnancy or breastfeeding
  • Hormone-sensitive cancers (breast, prostate, ovarian)
  • Severe pituitary or hypothalamic disease
  • Undiagnosed abnormal vaginal bleeding
  • Known hypersensitivity to GnRH

Triptorelin

Evidence level
Strong human trials (Phase 3 or FDA approved)
FDA status
FDA approved for this use
Safety overview
Triptorelin (GnRH agonist) has extensive FDA-approved safety data spanning decades for prostate cancer, endometriosis, and precocious puberty indications. Initial testosterone surge upon initiation ("flare reaction") can worsen prostate cancer or spinal cord compression symptoms, requiring careful patient monitoring in first 1-2 weeks and use of androgen antagonists in high-risk patients. Hypogonadal effects including hot flashes, sexual dysfunction, and bone loss develop predictably with chronic GnRH suppression; bone density monitoring is recommended in patients on therapy >6 months.

Contraindications

  • Pregnancy (can affect fetal development)
  • Undiagnosed vaginal bleeding
  • Known hypersensitivity to GnRH agonists
  • Severe untreated depression
  • Active spinal cord compression in prostate cancer (requires urgent decompression)

Decision guide

Which is right for you?

Gonadorelin (GnRH)

Choose Gonadorelin (GnRH) if…

  • Improving fertility and conception chances
  • Regulating irregular menstrual cycles
  • Enhancing reproductive hormone levels
  • Supporting natural pregnancy attempts

Triptorelin

Choose Triptorelin if…

  • Managing advanced prostate cancer when combined with other treatments
  • Relieving severe endometriosis pain and symptoms
  • Delaying puberty development in children with early sexual maturation